drugset / Trial / NCT04050020

Platelet-rich Plasma (PRP) Injection for Treatment of Erectile Function

NCT04050020

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of the present study is to investigate and compare the treatment efficacy of PRP injection vs placebo treatment in men with mild-moderate vasculogenic ED, as measured by IIEF.The secondary objective of the present clinical trial is to study the adverse events and safety of the PRP injection treatment in vasculogenic ED patients

Timeline

Start
2019-09-02
Primary completion
2020-03-26
Completion
2020-09-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Platelet Rich Plasma Other / unclassified 10 ml Other